Yakup Ergün· @dr_yakupergun · X·· 2 天前评分70
正文 · 原文
#ESMO26 | SAFFRON | Presidential Session-2
In EGFR-mutant, MET-overexpressed/amplified advanced NSCLC after osimertinib:
Osimertinib + savolitinib vs platinum-pemetrexed:
🔹 PFS: 7.6 vs 5.4 mo (HR 0.55)
🔹 OS: 17.8 vs 12.9 mo(HR 0.68)
27 浏览 · 0 赞 · 0 转发 · 0 回复
来源：Yakup Ergün · x.com